期刊文献+

液相色谱-质谱-质谱联用法测定人血浆中阿德福韦的浓度 被引量:4

Determination of adefovir in human plasma by LC/MS/MS
下载PDF
导出
摘要 目的:建立快速、灵敏的液相色谱-质谱-质谱联用(LC-MS-MS)法测定人血浆中阿德福韦的浓度,并研究其在中国男性健康志愿者人体内的药动学。方法:以乙腈-0.1%甲酸为流动相,采用梯度洗脱,以5-溴尿嘧啶为内标。血浆样品经乙腈沉淀蛋白后用二氯甲烷提取,经ZorbaxXDB-C8柱分离后,通过电喷雾离子化三重四极杆串联质谱仪,以多反应检测(MRM)方式进行测定。结果:阿德福韦的线性范围为0.167~83.3μg.L-1(r=0.9989),平均相对回收率在88.3%~110.0%之间,日内、日间精密度的RSD均小于12%,阿德福韦的定量下限为0.167μg.L-1。结论:该方法具有快速、准确、灵敏等优点,适用于阿德福韦的药动学研究。 OBJECTIVE To establish a rapid and sensitive LC/MS/MS method for the determination of adefovir in human plasma to investigate the pharmacokinetics of adefovir in healthy male Chinese volunteers. METHODS The mobile phase consisted of acetonitrile and 0.1% formic acid, 5-brorno uracil was used as internal standard. Plasma samples were precipitated with acetonitrile, then extracted using dichloromethane and separated through a Zorbax XDB-C8 column with gradient elution and detected by tandem mass spectrometry with an ESI interface. MRM was used for the determination of adefovir in human plasma. RESULTS Standard curve was linear in the range of 0. 167-83.3 μg·L^-1 (r = 0. 998 9), the relative recovery was between 88.3%-110. 0%. RSD of inter-and intra-day assays were all less than 12%. The quantification limit was 0. 167 μg·L^-1. CONCLUSION The method was suitable for pharmacokinetic studies of adefovir with the advantages of high speed, accuracy and sensitivity.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第7期894-897,共4页 Chinese Journal of Hospital Pharmacy
关键词 阿德福韦 液相色谱-质谱-质谱联用 药动学 adefovir LC-MS-MS pharmacokinetics
  • 相关文献

参考文献9

  • 1Adrian S. Ray,Jennifer E. Vela,Loren Olson,et al. Effective metabolism and long intracellular half life of the anti Hepatitis B agent adefovir in hepatic cells[J]. Biochemical Pharmacology,2004,68 : 1825-1831.
  • 2Heathcote EJ, Jeffers L, Perrilo R, et al, Serum HBV DNA suppression and seroconversion following long-term adefovir dipivoxil therapy in chronic hepatitis B patients[J]. Hepatology,2001,34:316A.
  • 3Cundy KC,Fishback JA,Shaw JP,et al. Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) from three formulations of the prodrug his (pivaloyloxymethyl)-PMEA in fastedmale cynomolgus monkeys [J]. Pharmceutical Research, 1994,11 (6):839-843.
  • 4武向峰,柴逸峰,沈娟,刘俊,娄子洋,李科.RP-HPLC法测定阿德福韦酯片中阿德福韦酯含量和有关物质[J].药物分析杂志,2005,25(5):573-575. 被引量:8
  • 5Shaw JP, Louie MS, Krishnamurthy VV, et al. Pharmacokinetics and metabolism of selected prodrug of PMEA in rat[J]. Drug Metabolism Disposition, 1997,25(3):362.
  • 6徐智儒,蒋晔,张晓青.高效液相色谱-荧光检测法测定大鼠生物样品中阿德福韦[J].药物分析杂志,2004,24(5):505-508. 被引量:4
  • 7Zhong Da-fang, Chen Xiao-yan, Liu Dan.Determination and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of adefovir in human plasma[J]. Rapid Commun. Mass Spectrom, 2005,19: 1893-1898.
  • 8Liu Yi-fei, Xu Gui-fen, Liset Garcia, et al. Ultra sensitive method for the determination of 9-(2-phosphonylmethoxyethyl) adenine in human serum by liquid chromatography/tandem mass spectrometry[J]. Journal of Chromatography B, 2004, 803 : 293-298.
  • 9钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581

二级参考文献10

  • 1ZHAOLi—YaIl(赵丽艳) CHEN)(iao—Yan(陈笑艳) ZHANGYong(张勇) etal.Determination of adefovir in macaque plasma byliquid chromatography—tandem nms spectrometry(液相色谱—质谱—质谱联用法测定猕猴血浆中阿德福韦)[J].Acta Pharm Sm,2003,38(2):120-120.
  • 2Shaw J P, Louie M S, Krishnamurthy V V ,et al. Pharmacokinetics and metabolism of selected prodmg of PMEA in rats. Drug Metabolism Disposition, 1997,25 ( 3 ) :362.
  • 3Naesens L, Balzarini J, and Clereq E D. Aeyelie Adenine nueleoaide phosphonates in plasma determined by high - performance liquid chromatography with fluorescence detection. Clin Chem, 1992, 38(4) :480.
  • 4许禄,化学计量学方法,1995年
  • 5萧参,中国药学杂志,1993年,28卷,425页
  • 6Marcellin P. Advances in therapy for chronic hepatitis B. Semin Liver Dis ,2002,22( Suppl 1 ) :33.
  • 7Karayiannis P. Hepatitis B virus:old, new and future approaches to antiviral treatment. J Antimicrob Chemother,2003,51 (4) :761.
  • 8Noble S,Goa KL. Adefovir dipivoxil. Drugs,1999,58(3) :479.
  • 9Colledge D, Civitico G, Locarnini S. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir. Antimicrob Agents Chemother,2000,44( 3 ) :551.
  • 10姚光弼.核苷类抗乙肝病毒药物研究近况[J].中国新药与临床杂志,2002,21(6):370-374. 被引量:19

共引文献589

同被引文献32

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部